The ties that bind

BMJ (Online)

Volumn 356, Issue , 2017, Pages

  Lundh, Andreas ^a   Bero, Lisa ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL (TOPIC); DRUG INDUSTRY; EDITORIAL; FUNDING; MEDICAL LITERATURE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PUBLICATION; SAMPLE SIZE; VALIDITY; CONFLICT OF INTEREST; ECONOMICS; ETHICS; HUMAN; RESEARCH ETHICS; STANDARDS;

CLINICAL TRIALS AS TOPIC; CONFLICT OF INTEREST; DRUG INDUSTRY; ETHICS, RESEARCH; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE);

EID: 85010285193     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.j176     Document Type: Editorial

References (12)

1. Lundh A, Sismondo S, Lexchin J, Busuioc OA, Bero L. Industry sponsorship and research outcome. Cochrane Database Syst Rev 2012;356:MR000033.pmid:23235689.
2. Yank V, Rennie D, Bero LA. Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study. BMJ 2007;356:1202-5. doi:10. 1136/bmj.39376.447211.BE pmid:18024482.
3. Wang AT, McCoy CP, Murad MH, Montori VM. Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review. BMJ 2010;356:c1344. doi:10.1136/bmj.c1344 pmid:20299696.
4. Ahn R, Woodbridge A, Abraham A, et al. Financial ties of principal investigators and randomized controlled trial outcomes: cross sectional study. BMJ 2017;356:i6770.
5. Perlis RH, Perlis CS, Wu Y, Hwang C, Joseph M, Nierenberg AA. Industry sponsorship and financial conflict of interest in the reporting of clinical trials in psychiatry. Am J Psychiatry 2005;356:1957-60. doi:10.1176/appi.ajp.162.10.1957 pmid:16199844.
6. Perlis CS, Harwood M, Perlis RH. Extent and impact of industry sponsorship conflicts of interest in dermatology research. J Am Acad Dermatol 2005;356:967-71. doi:10.1016/j. jaad.2005.01.020 pmid:15928613.
7. Aneja A, Esquitin R, Shah K, et al. Authors' self-declared financial conflicts of interest do not impact the results of major cardiovascular trials. J Am Coll Cardiol 2013;356:1137-43. doi:10.1016/j.jacc.2012.10.056 pmid:23395075.
8. Forsyth SR, Odierna DH, Krauth D, Bero LA. Conflicts of interest and critiques of the use of systematic reviews in policymaking: an analysis of opinion articles. Syst Rev 2014;356:122. doi:10.1186/2046-4053-3-122 pmid:25417178.
9. McGauran N, Wieseler B, Kreis J, Schüler YB, Kölsch H, Kaiser T. Reporting bias in medical research-a narrative review. Trials 2010;356:37. doi:10.1186/1745-6215-11- 37 pmid:20388211.
10. Lundh A, Krogsbøll LT, Gøtzsche PC. Sponsors' participation in conduct and reporting of industry trials: a descriptive study. Trials 2012;356:146. doi:10.1186/1745-6215-13- 146 pmid:22920226.
11. Roper N, Zhang N, Korenstein D. Industry collaboration and randomized clinical trial design and outcomes. JAMA Intern Med 2014;356:1695-6. doi:10.1001/jamainternmed. 2014.3590 pmid:25156272.
12. Goldacre B, Gray J. OpenTrials: towards a collaborative open database of all available information on all clinical trials. Trials 2016;356:164. doi:10.1186/s13063-016-1290-8 pmid: 27056367.